thalassaemia Archives -

Blood cells grown in a laboratory have been given to people for the first time in a clinical

First human trials of lab-grown red blood cells start in UK

https://pharmaphorum.com/news/first-human-trials-of-lab-grown-red-blood-cells-start-in-uk/

Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion

Novo Nordisk steps up sickle cell push with $1.1bn Forma buy

https://pharmaphorum.com/news/novo-nordisk-steps-up-sickle-cell-push-with-1-1bn-forma-buy/

Patients with sickle cell disease are facing racism in the NHS that is putting their lives a risk,

Parliamentary probe finds racism evidence in NHS sickle cell care

https://pharmaphorum.com/news/parliamentary-probe-finds-racism-evidence-in-nhs-sickle-cell-care/

UK biotech Silence Therapeutics has launched an online game to raise the profile of the rare blood disorder

Silence Tx uses game to raise thalassaemia awareness

https://pharmaphorum.com/news/silence-tx-uses-game-to-raise-thalassaemia-awareness/

bluebird bio is pricing its thalassaemia gene therapy Zynteglo at €1.57 million ($1.8 million) in Europe, but with

bluebird offers instalment payments for Zynteglo gene therapy

https://pharmaphorum.com/news/bluebird-offers-instalment-payments-for-zynteglo-gene-therapy/

It’s shaping up to be a landmark year for the community of patients with rare blood disorder beta

Celgene gets speedy review for thalassaemia drug luspatercept

https://pharmaphorum.com/news/celgene-gets-speedy-review-for-thalassaemia-drug-luspatercept/

thalassaemia